Summary. One month after streptozotocin treatment, basal rate in spontaneously beating fight atria was decreased and basal developed force in electrically-driven fight ventricular tissue was increased. Atrial sensitivity to the chronotropic effects of isoproterenol was not altered. In contrast, sensitivity in ventricular tissue to the inotropic effects of isoproterenol was decreased while sensitivity to calcium was increased. Associated with these changes was a decrease in myocardial fladrenoceptor density. Data obtained 3 and 6 months after streptozotocin treatment were similar to the observed alterations at 1 month. These results suggest that alterations in the chronotropic and inotropic responses that are expressed within 1 month after streptozotocin treatment do not significantly progress during the 6 months following induction of diabetes. They therefore reveal the independence of myocardial alterations from age of the animal and duration of diabetes (up to 6 months).
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Clinical observations reveal an increase in the incidence of cardiomyopathy among diabetic patients [1] [2] [3] [4] . Over the past decade, studies using the rat-diabetic model have demonstrated rapid development of cardiomyopathy after either alloxan or streptozotocin (STZ) treatment. Bradycardia, a consistent expression of experimental diabetes [5] [6] [7] [8] [9] has been reported to occur as early as 4days after induction of diabetes [10] . Depressed ventricular function initially observed in dogs [11] has also been shown to be a major manifestation of diabetes in rats [12] [13] [14] [15] .
There are few studies, however, dealing with the temporal relationship between experimental diabetes and ventricular dysfunction. In one study, depressed rat left ventricular papillary muscle function observed in 5-week STZ-diabetic animals was not found to deteriorate further as the duration of diabetes was increased to 30 weeks [16] . In a separate study, an absence of a further decrease in whole heart function in response to high atrial filling pressures after initial depression at 100 days after STZ treatment was reported [17] .
Previous studies in our laboratory using 1-month STZ-diabetic rats revealed the development of subsensitivity in isolated fight ventricular tissue to the inotropic effects of isoproterenol [18] . The subsensitivity phenomenon was accompanied by a decrease in ¢/-adrenoceptor number, and was also associated with supersensitivity to the inotropic effects of calcium [19] . The present study was initiated to determine the influence of a chronic diabetic state on isolated myocardial tissue responsiveness and sensitivity to chronotropic and inotropic agonists.
Materials and methods

Induction of experimental diabetes mellitus
Male Sprague-Dawley rats (150-200 g) were used in the present study. Streptozotocin (STZ, a gift from the Upjohn Co., Kalamazoo, Mich., USA) was dissolved in citrate buffer (0.10mol/l citric acid and 0.10mol/1 sodium citrate, pH 4.5). One group of animals received 65 mg/kg STZ through the tail vein [20] . A second group of animals, which were administered an equal volume of vehicle, served as agematched controls. Streptozotocin-treated and control animals were housed separately, two per cage, under alternating 12-h light and dark periods. The animals were maintained with free access to food (Purina Rat Chow, St. Louis, Mo, USA) and water for up to 6 months after treatment. At various times (1, 3 and 6 months) after STZ treatment, the animals were killed via decapitation and exsanguination.
Verification of the diabetic state
Rate of growth, plasma glucose and glycosylated haemoglobin (HbA0 levels were used to confirm the presence of diabetes mellitus after STZ treatment. Plasma glucose levels were determined in fresh blood samples as described previously [19, 21] . Glycosylated haemoglobin levels were determined using a Glyc-Affin column separation system obtained from ISO Lab Inc. (Akron, Ohio, USA).
Tissue preparations
Isolation of cardiac tissues was done according to our earlier described procedure [19] . At the time of killing, hearts were excised and immediately placed in a beaker containing cold oxygenated Chenoweth-Koelle solution (pH 7.4) consisting of (mmol/1): NaC1 (120.0); KCI (5.6); CaC12 (2.0); MgC12 (2.1); NaHCO3 (25.0); and dextrose (9.7). After expressing blood from the heart, the right atria was carefully dissected from the ventricles. The atrial tissue was then transferred to a fresh beaker containing cold Chenoweth-Koelle solution, and excess fat and the aorta were trimmed off. One end of the atrial tissue was then attached to a tissue-electrode assembly and the other to a force-displacement transducer connected to a Grass Model 79D polygraph four-channel recorder (Quincy, Mass, USA). A triangular shaped piece of right ventricular tissue was also obtained and mounted onto a similar assembly with two platinum electrodes. The other end was attached to a Grass FT.03 force-displacement transducer that was connected to the polygraph. The tissue preparations were equilibrated at 37 °C for 1 h in 20 or 50 ml baths of Chenoweth-Koelle solution under constant oxygenation (95% O~ and 5% CO2). During this period, Chenoweth-Koelle solution in the tissue bath was replaced every 10 min. Resting tensions in atria of 1 g and in right ventricle of 2g were maintained throughout the experiment. After 30min of equilibration, the ventricular strips were stimulated electrically via the punctate platinum electrodes (at a frequency of 1.6 Hz, 2 to 8V, and a duration of 5 ms). At the end of the equilibration period, basal rate in spontaneously beating atria and basal developed force in right ventricular tissue were recorded. Atrial preparations were used to study chronotropic responses and right ventricular tissue preparations to study inotropic responses. In addition, basal heart rates were recorded under pentobarbital (50mg/kg) or urethane (1.5g/kg) anaesthesia. Pentobarbital was used initially and was subsequently replaced by urethane (during the 3-and 6-month studies) due to its longer duration of action.
Agonist dose-response curves
Chronotropic and inotropic responses to isoproterenoh The fl-adrenoceptor agonist, isoproterenol (Sigma, St. Louis, Mo, USA), was prepared as a stock solution in acidifed saline (NaC1, 0.9%; ascorbic acid, 0.4 mg/dl; pH 6.0). The appropriate dilutions (3 x 10-4°-10 -5 mol/1) were made in Chenoweth-Koelle solution buffer. Chronotropic responses to cumulative additions of isoproterenol in isolated atrial and right ventricular tissues, respectively, were recorded when the responses had reached a steady-state level.
Tris-HC1 (50 mmol/1)-MgC12 (10 mmol/1) buffer (pH 7.4) and centrifuged at 40,000 g. This step was repeated twice. Membrane protein concentration was measured by the Lowry method [23] . The pellet was resuspended to give 2 mg protein/ml. A 100,1. aliquot of homogenate containing 100 to 200 Ixg of protein was used for the fl-adrenoceptor assay.
fl-Adrenoceptor binding assay : fl-Adrenoceptor assays were performed
by incubating protein with [3H]-DHA (New England Nuclear, Boston, Mass, USA; dihydroalprenolol, 0.3-15.0 nmol/1). Non-specific binding was measured in the presence of propranolol (Sigma; 10 ~xmol/1) [24] . The binding assay was carried out at 37 °C for 15 min in a total volume of 150 2. The reaction was terminated with 4 x 3 ml of icecold Tris-McCl2 buffer (pH 7.4), followed by rapid vacuum filtration through GF/C filters. The radioactivity (3H) bound to protein was measured using a scintillation counter. Specific binding (3-7% of total cpm) was determined by subtracting non-specific binding (1-2% of total cpm) from total binding. Binding sites and affinity for [3H]-DHA were determined according to Scatchard analysis [25] .
Statistical analysis
All results were converted to the mean and standard error of the mean. Geometric mean effective concentration (ECho) values were used to measure changes in sensitivity [26] . Student's t-test was used to determine significance between drug-treated and age-matched control groups. Results from temporal studies were analyzed using analysis of variance and Duncan's Student's multiple range test. A p value less than 0.05 was considered significant.
Results
Streptozotocin and indices of diabetes mellitus
Streptozotocin-treated animals exhibited polyphagia, polydipsia, hyperphagia, lethargy, discoloration of fur and were found to develop cataracts between 3 and 6 months after STZ treatment. Decreased rate of growth and elevations in blood glucose and glycosylated haemoglobin levels were also observed in the STZ-treated animals relative to age-matched controls (Fig. 1) .
Inotropic response to calcium
At the end of the equilibration period, the concentration of calcium in the bathing medium was decreased from 2.00 to 0.02 mmol/1. This resulted in a gradual decline of basal developed force to levels that could not be measured. Inotropic responses were obtained by cumulative additions of calcium up to 4 mmol/1. Responses were allowed to attain a steady state level with each dose before addition of the subsequent dose.
fl-Adrenoeeptor binding assay in the heart
Cardiac membrane preparation: Myocardial membrane preparations for radioligand binding assays were obtained as described previously [22] . In brief, ventricular tissue obtained from a minimum of :three hearts was minced in 4 x (by wet weight) volume of ice-cold sucrose (0.25 mol/1)-Tris-HC1 (10 mmol/1) buffer (pH7.4). The mince was centrifuged at 1,200 g for 10 min at 0 °C. The pellet was resuspended and centrifuged again. The resulting pellet was homogenized using a Brinkman polytron (2 x 20 s at a setting of 5), and centrifuged at 12,000 g for 10 min. The supernatant was passed through two layers of 4 x 4 gauze and centrifuged at 40,000 g for 60 min. The pellet consisting of the cardiac membrane fraction was resuspended and washed in
Chronotropic and inotropic responses in the heart
Temporal in vivo heart rates. In vivo heart rates were found to be consistently decreased (p < 0.05) at all studied periods in the STZ groups relative to the agematched control groups. The heart rate values (beats/ min) recorded in the control (C) and STZ groups at 1, 3 and 6months, respectively, were as follows: C (3) 390 _+ 7 and STZ (4) 288 +/9; C (4) 375 + 24 and STZ (5) 279_+14; C (4) 333 _+5 and STZ (7) 229_+25.
Temporal chronotropie responses in spontaneously beating right atria: Chronotropic responses to isoproterenol obtained at 1, 3 and 6 months are shown in Table 1 . Basal spontaneous atrial rate in the control group at 6months was found to be greater (p<0.05) than at 3 months. In the STZ group, basal atrial rate at 1 and 6months was found to be greater (p <0.05) than at 3 months. Maximum chronotropic responses to isoproterenol in the control and STZ groups at 6 months were found to be greater (p < 0.05) than at 1 and 3 months. Sensitivity to isoproterenol in the control group at i and 3 months was found to be greater (i. e. lower geometric mean ECs0, p < 0.05) than at 6 months. Sensitivity of the STZ group at 3 months was found to be greater (p < 0.05) than at 6 months.
Basal spontaneous atrial rate in tissues isolated from STZ-treated animals was significantly lowered (p < 0.05) relative to the age-matched control groups at all studied periods. Maximum chronotropic response to isoproterenol in the STZ group was found to be similarly depressed (p < 0.05) at 1 and 6 months when compared with the age-matched control groups. However, sensitivity to isoproterenol was not altered at any time after STZ treatment.
Temporal inotropic responses in electrically-driven right ventricle:
Relative to the age-matched control groups, basal developed force in tissues isolated from STZtreated animals was found to be elevated at all time periods, p < 0.05. Data (g) in the control (C) and STZ groups are representative of tissues used to obtain responses to isoproterenol or calcium at 1, 3 and 6 months, respectively: C (30) Maximum responses to the inotropic effects of isoproterenol were not found to be altered by STZ treatment at 1 and 6 months, but increased at 3 months relative to the age-matched control groups. The maximal responses (g) obtained in the control (C) and STZ groups at 1, 3 and 6 months, respectively, were as follows: C (19) Dose-response curves to isoproterenol obtained in the STZ groups were shifted to the right of the corresponding age-matched control groups at all time periods ( Fig. 2) , indicative of subsensitivity to the inotropic effects of isoproterenol. The decrease in sensitivity to isoproterenol was a reflection of higher geometric mean ECs0 values obtained in the STZ groups relative to the age-matched control groups ( Table 2) .
Comparison of the basal developed force values obtained over the 6-month period with corresponding isoproterenol ECs0 values revealed the persistence of subsensitivity of the STZ group relative to the control group over the range of basal developed forces observed (Fig. 3) .
Maximum inotropic responses to calcium in the STZ group were not found to be altered at 1 and 6 months but increased at 3 months relative to the agematched control groups. The maximum responses (g) obtained in the control (C) and STZ groups at 1 , 3 and 6 months, respectively, were as follows: C (11) 1.075 0.14 and STZ (18) 1.14 t 11 ; C (9) 1.01 + 0.12 and STZ (12) In contrast to isoproterenol, dose-response curves to Ca2+ obtained in the STZ groups were found to be shifted to the left of the corresponding age-matched control groups at all time periods (Fig.4) , indicative of BASAL DEVELOPED FORCE (g) Fig.3 . Relationship between isoproterenol geometric mean ECsa values and corresponding basal developed forces. The values represent a composite of data obtained using right ventricular strips isolated from I-, 3-and 6-month STZ-treated ( 0 -0 ) and age-matched control (@-@) animals. Values in parentheses represent number of tissues supersensitivity to the inotropic effects of Ca2+. The increased sensitivity to Ca2+ was a reflection of lower geometric mean EC5() values obtained in the STZ groups relative to the age-matched control groups ( Table 2) .
Comparison of the basal developed force values obtained over the 6-month period with corresponding Ca2+ ECS0 values revealed the persistence of supersensitivity of the STZ group relative to the control group over the range of basad developed forces observed (Fig. 5) . (Table 3) . However, neither affinity (KD) of the receptor, nor heart protein yield, were significantly altered by STZ treatment.
be elevated in the STZ group at 3 months when compared with 1 month. The variability in Bmax values observed among the control and STZ groups was related to the fact that the 1-, 3-and 6-month studies were performed separately and at different times. However, the percentage decrease in fl-adrenoceptor density in the STZ groups relative to the age-matched control groups remained similar.
Temporal relationships in the ventricle
The following parameters were not found to be significantly altered with time in either control or STZ groups: basal developed force, and inotropic sensitivity to isoproterenol and calcium. While maximum responses to isoproterenol and calcium in the control groups were not affected by the duration of study they were found to
Discussion
The "classical signs" of human diabetes include elevations in blood glucose, glycosuria, polydipsia, polyuria and hyperphagia [27] . In the present study, these features were observed in the rat after streptozotocin administration. Blood glucose levels in the STZ group were found to be significantly elevated when first determined at 3 days. During the course of the 6 months, they remained elevated in the absence of spontaneous recovery from the diabetogenic effects of STZ, similar to previous studies [16, 17, 28] . Glycosylated haemoglobin, in contrast to blood glucose, did not reach a steady-state level until 3 months after STZ treatment. This is expected, since glycosylation of haemoglobin proceeds continuously and irreversibly during the 3-month life span of a mammalian erythrocyte [29] .
Earlier studies in our laboratory demonstrated myocardial abnormalities in rats 1 month after induction of diabetes with STZ. These included: bradycardia, elevated ventricular basal developed force, inotropic subsensitivity to isoproterenol, inotropic supersensitivity to calcium and decreased fl-adrenoceptor density [18, 19] . The diabetic state produced in the present study, as described earlier, was associated with a decreased rate of growth. The deleterious effects of chronic under-nutrition on heart function, while not examined in the present study, have been investigated in other laboratories. Streptozotocin-induced depressions in myocardial function [14, 16] and biochemical parameters such as actinomysin calcium-ATPase activity [30] and fl-adren0ceptor density [31] were not found to be present in nbn-diabetic rats whose food had been restricted. Thus, it might be proposed that diabetes-induced malnutrition is not the major cause of myocardial abnormalities observed in the present study. These alterations were als0 ~ound not to be a result of direct cardiotoxic effects of STZ [32, 33] . The objective of the present study, therefore, was to distinguish between the effects of the diabetic state and duration of diabetes in the heart.
Relative to the age-matched control groups, bradycardia, decreased maximum chronotropic responses to isoproterenol (with the exception of 3 months) and absence of sensitivity changes to the chronotropic effects of isoproterenol were observed at all time periods in the STZ group. Even though some variation within the control and STZ groups was apparent during the course of the study, the differences between the two remained.
Bradycardia has been observed as early as 4 days after STZ treatment [10] . In the uncontrolled state, lowered heart rates persisted for the duration of the study (14 weeks) . This is in agreement with the data obtained in the present study, which revealed a consistent occurrence of bradycardia for 24 weeks after STZ treatment. Possibility of damage to atrial tissue during isolation resulting in bradycardia was dismissed when in vivo heart rates were also found to be depressed in the STZ groups. In addition, the data obtained under in vivo conditions indicated that bradycardia was not an indirect result of differences in the ion or glucose concentrations used in the buffer medium under in vitro conditions.
Bradycardia has been proposed to be due to alterations in SA nodal electrical activity as a result of hyperglycaemia [34, 35] , reduced myocardial lipid metabo-lism [11, 36] , or hypothyroidism [37, 38] . The mechanism(s) by which bradycardia is produced by these abnormalities, however, has not yet been elucidated.
The present observations of a lack of change in chronotropic sensitivity is in contrast to the findings of Foy and Lucas [6] . These authors reported an elevated basal contractile force associated with isolated auricle subsensitivity to isoproterenol. One difference in the two studies is the concentration of glucose used in the medium. Foy and Lucas [6] used a concentration of 5.6 mmol/l, while in the present study 9.7 mmol/1 was used. It has been suggested that an increase in work by hearts of diabetic rats raised glucose uptake to normal [39] . Thus, it is reasonable to speculate that the glucose concentration used in studies performed by Foy and Lucas [6] , as opposed to the present study, was a limiting factor. Whether this is an important factor in regulating sensitivity to isoproterenol is not known.
Ventricular alterations observed in the 1-month STZ-treated animals were also evident at 3 and 6 months. Elevations in basal developed force, and inotropic subsensitivity to isoproterenol and supersensitivity to calcium were not found to be significantly influenced by the duration of diabetes. Decreased fl-adrenoceptor density in the absence of a change in receptor affinity was also persistent during the 6-month period.
This lack of significant progression in myocardial abnormalities is consistent with previous long-term studies. Fein et al. [16] , using the rat left ventricular papillary muscle preparation, reported depressed myocardial mechanics as early as 5 weeks after STZ treatment. The changes, however, did not worsen as the duration of diabetes was increased to 35 weeks. Similarly, Vadlamudi et al. [17] observed depressed positive and negative rate of force development in the working heart preparation of rats at 13 weeks after induction of diabetes with STZ. However, as the study was extended to 52 weeks, further depression of function was not evident.
The present data suggest that alterations in myocardial inotropic sensitivity in the STZ group are not related to elevations in the basal developed force. Other data obtained in our laboratory indicate that the functional alterations in the ventricle are not due to changes in the tissue norepinephrine content and release from the heart [18] , choices in the resting tension and frequency of stimulation [19] , the glucose concentration in the medium [33] or to direct cardiotoxic effects of STZ [32, 33] .
In view of the presence of ventricular subsensitivity to isoproterenol in the diabetic hearts, it is of interest to note that decreases in isoproterenol-stimulated adenylate cyclase activation [40] , cyclic AMP responses [40] [41] [42] and calcium influx [43] have also been observed in STZ-diabetic animals. The possibility of these alterations influencing inotropic sensitivity in diabetic animals to fl-stimulation is currently under investigation. Involvement of diabetes-induced alterations in the fladrenoceptor system contributing to the subsensitivity phenomenon is also suggested by the concomitant occurrence of supersensitivity to the receptor-independent inotropic effects of calcium. The question of whether the changes in myocardial sensitivity to calcium and isoproterenol are occurring independently or in a compensatory fashion will be addressed in future studies.
In summary, the present study reveals that myocardial alterations observed after STZ treatment are independent of duration of diabetes (up to 6 months). Increase in the age of the animal also does not appear to contribute to the observed alterations since the same parameters studied in ventricular tissue obtained from control animals did not progress significantly with time. They further indicate that the 1-month diabetic state is a suitable model for studies dealing with the elucidation of the factor(s) responsible for myocardial abnormalities observed after STZ treatment.
